Ratings by Brookline Capital Markets
| Date | Analyst | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|---|
| 5/20/2026 | N/A | ProMIS Neurosciences | PMN | New Coverage | Buy (N/A) |
40.00 (N/A) |
10.65 (9.65) |
-9.39% | Details |
| 5/7/2026 | N/A | Ernexa Therapeutics | ERNA | New Coverage | Buy (N/A) |
30.00 (N/A) |
6.04 (8.01) |
32.62% | Details |
 |
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
| 294 more... | |||||||||
